zopiclone has been researched along with pk 11195 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anzini, M; Basile, AS; Bruni, G; Cappelli, A; Giorgi, G; Langer, T; Romeo, MR; Vomero, S | 1 |
| Cuparencu, B; Horák, A; Horák, J | 1 |
2 other study(ies) available for zopiclone and pk 11195
| Article | Year |
|---|---|
Molecular basis of peripheral vs central benzodiazepine receptor selectivity in a new class of peripheral benzodiazepine receptor ligands related to alpidem.
Topics: Animals; Anti-Anxiety Agents; Binding, Competitive; Cerebral Cortex; Drug Design; Flunitrazepam; Imidazoles; Isoquinolines; Models, Molecular; Protein Conformation; Pyridines; Rats; Receptors, GABA-A; Structure-Activity Relationship | 1996 |
Acute effects of zopiclone on blood glucose level and serum lipids in hyperlipidemic rats. Interactions with PK 11195 and flumazenil.
Topics: Animals; Azabicyclo Compounds; Blood Glucose; Central Nervous System; Cholesterol; Flumazenil; GABA Modulators; Hyperlipidemias; Hypnotics and Sedatives; Isoquinolines; Lipids; Male; Peripheral Nervous System; Piperazines; Polyethylene Glycols; Rats; Rats, Wistar; Receptors, GABA-A; Triglycerides | 2000 |